Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
157.1 USD | -0.76% | -5.62% | +1.35% |
May. 23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
May. 23 | AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.35% | 277B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B | |
-0.27% | 121B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie, Genmab Say Phase 1/2 Trial of Epcoritamab in Follicular Lymphoma Patients Showed 82% of Overall Response Rate